HanX Biopharmaceuticals, Inc.

Industry

  • Pharmaceuticals
    • Vaccines
  • Biotechnology
    • Large Molecule
      • Antibodies
See more in Biomedtracker

Latest on HanX Biopharmaceuticals, Inc.

Scrip

Asia Deal Watch: China’s BravoVax, US-based GeoVax Team Up On Coronavirus Vaccine

 
• By Ian Haydock, Vibha Ravi, Anju Ghangurde, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . US, Chinese Vaccine Develope

Scrip

Deal Watch: AstraZeneca Continues Divestments By Offloading US/Canada Seroquel Rights

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . AstraZeneca Calls On Cheplap

Scrip

Deal Watch: Parvus Signs Second Big Pharma Alliance, With Genentech

 
• By Joseph Haas, Ian Haydock, and Anju Ghangurde

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions . Parvus, Genentech Collaborat

In Vivo

Deals Shaping the Medical Industry, January 2018

 
• By Beth Allan, Deanna Kamienski, and Maureen Riordan

IN VITRO DIAGNOSTICS Alliances Oxford Immunotec Global PLC Qiagen NV Oxford Immunotec Global PLC and Qiagen NV have settled patent infringement litigation surrounding Qiagen's QuantiFERON-TB